发明名称 Cytostatic substances
摘要 <p>2(R or S)-[2R-(S-Hydroxy-hydroxycarbamoyl-methyl)-4-methyl-pentanoylaminel]-2-phenyl-ethanoic acid cyclopenty ester' 2(R or S)-(3S-Hydroxycarbamoyl-2R-isobutyl-hex-5-enoylamino)-2-phenylethanoic acid isopropyl ester; 2(R or S)-[2R-(S-Hydroxycarbamoyl-methoxy-methyl)-4-methyl-pentanoylamino]-3-phenylethanoic acid cyclopentyl ester; 2(R or S-(3S-Hydroxycarbamoyl-2R-isobutyl-hex-5-enoylamino)-2-(4-methoxyphenyl)ethanoic acid cyclopentyl ester; 2(R or S)-(3S-Hydroxycarbamoyl-2R-isobutyl-hex-5-enoylamino)-2-(thien-2-yl)ethanoic acid cyclopentyl ester; and 2(R or S)-(3S-Hydroxycarbamoyl-2R-isobutyl-hex-5-enoylamino)-2-(thien-3-yl)ethanoic acid cyclopentyl ester are cytostatic agents.</p>
申请公布号 CZ20003317(A3) 申请公布日期 2001.03.14
申请号 CZ20000003317 申请日期 1998.03.12
申请人 BRITISH BIOTECH PHARMACEUTICALS LIMITED 发明人 PEARSON LINDSEY ANN;AYSCOUGH ANDREW PAUL;HUXLEY PHILIP;DRUMMOND ALAN HASTINGS
分类号 A61K31/216;A61K31/22;A61K31/38;A61K31/381;A61P35/00;C07C259/06;C07D333/24;(IPC1-7):C07C259/06 主分类号 A61K31/216
代理机构 代理人
主权项
地址